Zobrazeno 1 - 10
of 5 793
pro vyhledávání: '"hepatitis b surface antigen"'
Autor:
Lina Wu, Jiadi Lai, Qiumin Luo, Yeqiong Zhang, Chaoshuang Lin, Dongying Xie, Youming Chen, Hong Deng, Zhiliang Gao, Liang Peng, Wenxiong Xu
Publikováno v:
Liver Research, Vol 8, Iss 3, Pp 179-187 (2024)
Background and aim: Few studies have reported hepatitis B surface antigen (HBsAg) kinetics after nucleos(t)ide analog (NA) discontinuation in patients with noncirrhotic chronic hepatitis B (CHB). The study specifically investigated long-term HBsAg ki
Externí odkaz:
https://doaj.org/article/415b38de27784d988b5083a1ef4ab88c
Autor:
Yuying Li, Siqi Yang, Cong Li, Zhenjie Ma, Mengmeng Zhang, Wenhang Zou, Zihao Wu, Haiyan Hou, Weixing Wang, Liying Zhu
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-9 (2024)
Abstract Purpose Peginterferon alfa-2b (Peg-IFN α-2b) has demonstrated superior efficacy over nucleos(t)ide analogs (NAs) in the treatment of chronic hepatitis B (CHB), particularly among patients with low levels of hepatitis B surface antigen (HBsA
Externí odkaz:
https://doaj.org/article/16deed8fddd645a9b4ee0c28934269ff
Publikováno v:
Nigerian Journal of Paediatrics, Vol 44, Iss 1, Pp 14-21 (2024)
Background: Majority of secondary school students are adolescents; an age group with a tendency to engage in health- compromising risky behaviours in order to deal with anxiety and gain admission to peer groups. This exposes them to risk of Hepatitis
Externí odkaz:
https://doaj.org/article/d47f14e96d8447f3a06e87189885f1bd
Autor:
Anna S. F. Lok
Publikováno v:
Gut and Liver, Vol 18, Iss 4, Pp 593-601 (2024)
Current treatment of chronic hepatitis B virus (HBV) infection, pegylated interferon-α (pegIFN-α) and nucleos(t)ide analogue (NA), can suppress HBV replication, reverse liver inflammation and fibrosis, and decrease risks of cirrhosis and hepatocell
Externí odkaz:
https://doaj.org/article/cf9f566970f640ac8ddce25d7e3a5556
Autor:
Li Yadi, Luo Haiying, Hu Xiaoxia, Gong Jiaojiao, Tan Guili, Luo Huating, Wang Rui, Pang Hao, Yu Renjie, Qin Bo
Publikováno v:
Polish Journal of Microbiology, Vol 73, Iss 2, Pp 217-235 (2024)
Interferon-alpha (IFN-α) is a first-line drug for treating chronic hepatitis B (CHB). Guanylate-binding protein 1 (GBP1) is one of the interferon-stimulating factors, which participates in the innate immunity of the host and plays an antiviral and a
Externí odkaz:
https://doaj.org/article/9dae418c70fe47b6969af8e87be24f0e
Publikováno v:
Shanghai yufang yixue, Vol 36, Iss 5, Pp 423-428 (2024)
ObjectiveTo explore the importance of post-vaccination serological testing (PVST) for children exposed to hepatitis B virus (HBV), and analyze the factors affecting the progress of PVST.MethodsThe study focused on hepatitis B surface antige
Externí odkaz:
https://doaj.org/article/759b3724572d4813bd34b0e5f4bfccaf
Publikováno v:
Journal of IMAB, Vol 30, Iss 2, Pp 5517-5521 (2024)
ABSTRACT: The purpose of this study is to determine the prevalence of stress among students of various health Hepatitis B virus (HBV) infection is a significant cause of morbidity and mortality and a leading cause of chronic liver disease. Vaccinati
Externí odkaz:
https://doaj.org/article/370986b75aa64d1bb399f1e5edf46ad8
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Existing research in Ethiopia has primarily focused on the individual epidemiology of HIV and HBV, often overlooking the intricate dynamics of co-infection. This study aims to address this gap by comprehensively exploring the prev
Externí odkaz:
https://doaj.org/article/20583f5cefdc4988b562feea8f66d904
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 10 (2024)
ABSTRACT Toll-like receptors (TLRs) play a crucial role in eliminating viral infection. Conversely, viruses have evolved various strategies to disrupt TLR signaling during chronic infection. In the case of hepatitis B virus (HBV), we previously repor
Externí odkaz:
https://doaj.org/article/b2968d2d090e4af1927132d928d6df19
Autor:
Zhiqiang Gu, Qianqian Jiang, Abudurexiti Abulaiti, Xiaojie Chen, Mingwei Li, Na Gao, Guiwen Guan, Ting Zhang, Danli Yang, Jingyuan Xi, Guangxin Yu, Shuhong Liu, Zhijun Zhu, Zhiliang Gao, Jingmin Zhao, Hongxin Huang, Xiangmei Chen, Fengmin Lu
Publikováno v:
JHEP Reports, Vol 6, Iss 9, Pp 101144- (2024)
Background & Aims: The expression of HBsAg from integrated HBV DNA limits the achievement of functional cure for chronic hepatitis B. Thus, characterising the unique expression and secretion of HBsAg derived from integrated HBV DNA is of clinical sig
Externí odkaz:
https://doaj.org/article/efe9dda4c22b4472b090196615ee1061